Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity...

Prof Gottfried Konecny - University of California, Los Angeles, USA

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers ( Prof Gottfried Konecny - University of California, Los Angeles, USA )

Total neoadjuvant treatment without surgery for locally advanced rectal cancer

Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy

Total neoadjuvant treatment without surgery for locally advanced rectal cancer ( Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy )

Immunotherapy resistance pathways investigated to tailor combination NSCLC...

Prof Pascale Tomasini - Aix-Marseille University, Marseille, France

Immunotherapy resistance pathways investigated to tailor combination NSCLC therapy ( Prof Pascale Tomasini - Aix-Marseille University, Marseille, France )

Radiation therapy for breast cancer can be safely shortened by changing...

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

Radiation therapy for breast cancer can be safely shortened by changing technique ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )

ESMO 2024: Latest in bladder cancer - expert review

Dr Patrizia Giannatempo, Prof Andrea Necchi, Prof Simon Crabb, Dr Michiel Van...

ESMO 2024: Latest in bladder cancer - expert review ( Dr Patrizia Giannatempo, Prof Andrea Necchi, Prof Simon Crabb, Dr Michiel Van Der Heijden )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )

Mutational-based treatment approach may significantly improve outcomes in...

Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours ( Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy )

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive...

Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer ( Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA )

ESMO 2024: Latest in EGFR mutated NSCLC

Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof...

ESMO 2024: Latest in EGFR mutated NSCLC ( Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip )

ESMO 2024: Latest updates in mRCC

Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane...

ESMO 2024: Latest updates in mRCC ( Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane Oudard )

Improved structure preservation with neo-adjuvant platinum-based chemo in...

Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC ( Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA )

More from ecancer